
The allegations of insider trading against Representative Christopher Collins have revived calls for stricter rules about financial investments or corporate board seats held by members of Congress. KATIE THOMAS and SHEILA KAPLAN https://ift.tt/2MekgiA https://ift.tt/2nuwLaE The New York Times Health Ethics and Official Misconduct, Biotechnology and Bioengineering August 11, 2018 at 12:00AM
Comments
Post a Comment